22 Jul 2020 Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies
21 Jul 2020 Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19
20 Jul 2020 Metaclipse Therapeutics Awarded Funding from NIAID for COVID-19 Vaccine Development
20 Jul 2020 Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
20 Jul 2020 COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
20 Jul 2020 GSK and CureVac announce strategic mRNA technology collaboration
20 Jul 2020 Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
17 Jul 2020 Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
16 Jul 2020 Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
16 Jul 2020 Virometix Announces Successful Closing of Series B Investment Round raising CHF 7.5 million
16 Jul 2020 AC Immune Advances phospho-Tau Alzheimer’s Vaccine in Phase 1b/2a Study
15 Jul 2020 COVAXX Announces First Multitope Peptide-Based Vaccine to Enter Human Trials
15 Jul 2020 ZYUS Announces Positive Milestone in Plant-Based COVID-19 Vaccine Antigen Production
15 Jul 2020 Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)
15 Jul 2020 Zydus starts human dosing of its vaccine ‘ZyCoV-D’
14 Jul 2020 Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA
14 Jul 2020 Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate
14 Jul 2020 IMV Updates Rapid Progress on COVID-19 Vaccine Program
13 Jul 2020 Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™
13 Jul 2020 Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
13 Jul 2020 Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
08 Jul 2020 CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate
08 Jul 2020 Novavax Announces $1.6 Billion Funding from Operation Warp Speed
07 Jul 2020 GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
07 Jul 2020 Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up